Patients with Hypertrophic Cardiomyopathy (HCM)
Highlights the importance of recognizing the heterogeneity of hypertrophic cardiomyopathy to direct individualized therapy.
HCM is a heterogeneous disease genotypically, phenotypically, pathophysiologically, clinically, and therapeutically. In decisions on the management of these patients, it is important to recognize this heterogeneity and to direct therapy at the predominant abnormalities.
Building similarity graph...
Analyzing shared references across papers
Loading...
E.Douglas Wigle
Harry Rakowski
Brian P. Kimball
Circulation
Toronto General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Wigle et al. (Sun,) studied this question.
www.synapsesocial.com/papers/69eff9e14f6a06657c21dd95 — DOI: https://doi.org/10.1161/01.cir.92.7.1680